INT J BIOL MACROMOL 润色咨询

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

出版年份:1979 年文章数:16068 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:16.7% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=858882, encodeId=d4a9858882d1, content=嗯,很快,已经接收3篇了,友好的期刊和审稿人,当然提出的修改意见很中肯,希望该期刊志能尽快跨入一区,突破5分,还会支持的! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48345414140, createdName=ms7269483029162029, createdTime=Sun Mar 29 11:19:51 CST 2020, time=2020-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157657, encodeId=17f2215e657b5, content=偏重的研究方向:生物大分子<br>经验分享:我9.1号投的,当天with editor ,到现在都还没动静。有没有一样的呀? 有点着急了,看这个期刊最近都超级慢 - -, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c78e8753922, createdName=ms3000000496472263, createdTime=Thu Sep 14 12:47:03 CST 2023, time=2023-09-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2178606, encodeId=dc1521e860647, content=审稿速度:1.0<br>偏重的研究方向:基础医学;综述;肿瘤治疗<br>经验分享:20231023 初次投稿<br>20231025 reject 综述需要在题目里带有review,修改重投<br>20231026 重新投稿,两三天之后under review<br>20231120 结束审稿,给了一个月大修<br>20231219 修回<br>20231222 又重新送回审稿人手里 under review<br>20231231 accept<br>全程有三个审稿人,一共提了20+个意见,审稿速度算飞速的了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Mon Jan 01 16:19:48 CST 2024, time=2024-01-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2186444, encodeId=2307218644450, content=没审稿,直接DIP 写信催给决定 ,回复以下,没动静了,有经验的大神在吗 怎么办 Your manuscript was transferred to our transfer team looking for a better suited journal. The transfer process may take a few days to complete.  When you receive a letter of confirmation of transfer, you can accept or decline the transfer. Best regards,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6a65458119, createdName=ms1000001139242253, createdTime=Thu Feb 08 05:53:18 CST 2024, time=2024-02-08, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向:分子生物学<br>经验分享:投稿第三天直接decision in process 请问这是直接拒稿吗?有没有相同经历的人 麻烦分享一下 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2170911, encodeId=33c021e09112b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:医学<br>经验分享:状态是with editor 之后变成 decision in process,这个状态要持续多久呀,已经一个礼拜了,也不送审。可以直接投下一个期刊吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20535460863, createdName=ms2000001577708140, createdTime=Sat Nov 25 12:53:20 CST 2023, time=2023-11-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了,外审时间都半年了,催了几次回复都一样。问一下大家,是不是审稿人不回复,编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2106235, encodeId=347b210623503, content=投稿一个月了,还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211226/b81eecd114f947a4b95c452618e5ebdc/32dc8969e6744e21929a0d643f10b777.jpg, createdBy=404c107315, createdName=Marvin2014, createdTime=Thu Dec 15 20:44:34 CST 2022, time=2022-12-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿,当天with editor。15号变成decision,现在还在等待决定。已经快一个月了,有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167530, encodeId=2f27216e53014, content=偏重的研究方向:生物材料<br>经验分享:两个月了 没有审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=Zhou zhongsheng, createdTime=Thu Nov 09 09:47:55 CST 2023, time=2023-11-09, status=1, ipAttribution=吉林省)]
    2020-03-29 ms7269483029162029

    嗯,很快,已经接收3篇了,友好的期刊和审稿人,当然提出的修改意见很中肯,希望该期刊志能尽快跨入一区,突破5分,还会支持的!

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=858882, encodeId=d4a9858882d1, content=嗯,很快,已经接收3篇了,友好的期刊和审稿人,当然提出的修改意见很中肯,希望该期刊志能尽快跨入一区,突破5分,还会支持的! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48345414140, createdName=ms7269483029162029, createdTime=Sun Mar 29 11:19:51 CST 2020, time=2020-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157657, encodeId=17f2215e657b5, content=偏重的研究方向:生物大分子<br>经验分享:我9.1号投的,当天with editor ,到现在都还没动静。有没有一样的呀? 有点着急了,看这个期刊最近都超级慢 - -, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c78e8753922, createdName=ms3000000496472263, createdTime=Thu Sep 14 12:47:03 CST 2023, time=2023-09-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2178606, encodeId=dc1521e860647, content=审稿速度:1.0<br>偏重的研究方向:基础医学;综述;肿瘤治疗<br>经验分享:20231023 初次投稿<br>20231025 reject 综述需要在题目里带有review,修改重投<br>20231026 重新投稿,两三天之后under review<br>20231120 结束审稿,给了一个月大修<br>20231219 修回<br>20231222 又重新送回审稿人手里 under review<br>20231231 accept<br>全程有三个审稿人,一共提了20+个意见,审稿速度算飞速的了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Mon Jan 01 16:19:48 CST 2024, time=2024-01-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2186444, encodeId=2307218644450, content=没审稿,直接DIP 写信催给决定 ,回复以下,没动静了,有经验的大神在吗 怎么办 Your manuscript was transferred to our transfer team looking for a better suited journal. The transfer process may take a few days to complete.  When you receive a letter of confirmation of transfer, you can accept or decline the transfer. Best regards,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6a65458119, createdName=ms1000001139242253, createdTime=Thu Feb 08 05:53:18 CST 2024, time=2024-02-08, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向:分子生物学<br>经验分享:投稿第三天直接decision in process 请问这是直接拒稿吗?有没有相同经历的人 麻烦分享一下 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2170911, encodeId=33c021e09112b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:医学<br>经验分享:状态是with editor 之后变成 decision in process,这个状态要持续多久呀,已经一个礼拜了,也不送审。可以直接投下一个期刊吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20535460863, createdName=ms2000001577708140, createdTime=Sat Nov 25 12:53:20 CST 2023, time=2023-11-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了,外审时间都半年了,催了几次回复都一样。问一下大家,是不是审稿人不回复,编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2106235, encodeId=347b210623503, content=投稿一个月了,还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211226/b81eecd114f947a4b95c452618e5ebdc/32dc8969e6744e21929a0d643f10b777.jpg, createdBy=404c107315, createdName=Marvin2014, createdTime=Thu Dec 15 20:44:34 CST 2022, time=2022-12-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿,当天with editor。15号变成decision,现在还在等待决定。已经快一个月了,有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167530, encodeId=2f27216e53014, content=偏重的研究方向:生物材料<br>经验分享:两个月了 没有审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=Zhou zhongsheng, createdTime=Thu Nov 09 09:47:55 CST 2023, time=2023-11-09, status=1, ipAttribution=吉林省)]
    2023-09-14 ms3000000496472263 来自四川省

    偏重的研究方向:生物大分子
    经验分享:我9.1号投的,当天with editor ,到现在都还没动静。有没有一样的呀? 有点着急了,看这个期刊最近都超级慢 - -

    3

    展开3条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=858882, encodeId=d4a9858882d1, content=嗯,很快,已经接收3篇了,友好的期刊和审稿人,当然提出的修改意见很中肯,希望该期刊志能尽快跨入一区,突破5分,还会支持的! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48345414140, createdName=ms7269483029162029, createdTime=Sun Mar 29 11:19:51 CST 2020, time=2020-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157657, encodeId=17f2215e657b5, content=偏重的研究方向:生物大分子<br>经验分享:我9.1号投的,当天with editor ,到现在都还没动静。有没有一样的呀? 有点着急了,看这个期刊最近都超级慢 - -, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c78e8753922, createdName=ms3000000496472263, createdTime=Thu Sep 14 12:47:03 CST 2023, time=2023-09-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2178606, encodeId=dc1521e860647, content=审稿速度:1.0<br>偏重的研究方向:基础医学;综述;肿瘤治疗<br>经验分享:20231023 初次投稿<br>20231025 reject 综述需要在题目里带有review,修改重投<br>20231026 重新投稿,两三天之后under review<br>20231120 结束审稿,给了一个月大修<br>20231219 修回<br>20231222 又重新送回审稿人手里 under review<br>20231231 accept<br>全程有三个审稿人,一共提了20+个意见,审稿速度算飞速的了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Mon Jan 01 16:19:48 CST 2024, time=2024-01-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2186444, encodeId=2307218644450, content=没审稿,直接DIP 写信催给决定 ,回复以下,没动静了,有经验的大神在吗 怎么办 Your manuscript was transferred to our transfer team looking for a better suited journal. The transfer process may take a few days to complete.  When you receive a letter of confirmation of transfer, you can accept or decline the transfer. Best regards,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6a65458119, createdName=ms1000001139242253, createdTime=Thu Feb 08 05:53:18 CST 2024, time=2024-02-08, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向:分子生物学<br>经验分享:投稿第三天直接decision in process 请问这是直接拒稿吗?有没有相同经历的人 麻烦分享一下 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2170911, encodeId=33c021e09112b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:医学<br>经验分享:状态是with editor 之后变成 decision in process,这个状态要持续多久呀,已经一个礼拜了,也不送审。可以直接投下一个期刊吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20535460863, createdName=ms2000001577708140, createdTime=Sat Nov 25 12:53:20 CST 2023, time=2023-11-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了,外审时间都半年了,催了几次回复都一样。问一下大家,是不是审稿人不回复,编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2106235, encodeId=347b210623503, content=投稿一个月了,还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211226/b81eecd114f947a4b95c452618e5ebdc/32dc8969e6744e21929a0d643f10b777.jpg, createdBy=404c107315, createdName=Marvin2014, createdTime=Thu Dec 15 20:44:34 CST 2022, time=2022-12-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿,当天with editor。15号变成decision,现在还在等待决定。已经快一个月了,有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167530, encodeId=2f27216e53014, content=偏重的研究方向:生物材料<br>经验分享:两个月了 没有审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=Zhou zhongsheng, createdTime=Thu Nov 09 09:47:55 CST 2023, time=2023-11-09, status=1, ipAttribution=吉林省)]
    2024-01-01 ms6000001594127539 来自上海

    审稿速度:1.0
    偏重的研究方向:基础医学;综述;肿瘤治疗
    经验分享:20231023 初次投稿
    20231025 reject 综述需要在题目里带有review,修改重投
    20231026 重新投稿,两三天之后under review
    20231120 结束审稿,给了一个月大修
    20231219 修回
    20231222 又重新送回审稿人手里 under review
    20231231 accept
    全程有三个审稿人,一共提了20+个意见,审稿速度算飞速的了。

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=858882, encodeId=d4a9858882d1, content=嗯,很快,已经接收3篇了,友好的期刊和审稿人,当然提出的修改意见很中肯,希望该期刊志能尽快跨入一区,突破5分,还会支持的! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48345414140, createdName=ms7269483029162029, createdTime=Sun Mar 29 11:19:51 CST 2020, time=2020-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157657, encodeId=17f2215e657b5, content=偏重的研究方向:生物大分子<br>经验分享:我9.1号投的,当天with editor ,到现在都还没动静。有没有一样的呀? 有点着急了,看这个期刊最近都超级慢 - -, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c78e8753922, createdName=ms3000000496472263, createdTime=Thu Sep 14 12:47:03 CST 2023, time=2023-09-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2178606, encodeId=dc1521e860647, content=审稿速度:1.0<br>偏重的研究方向:基础医学;综述;肿瘤治疗<br>经验分享:20231023 初次投稿<br>20231025 reject 综述需要在题目里带有review,修改重投<br>20231026 重新投稿,两三天之后under review<br>20231120 结束审稿,给了一个月大修<br>20231219 修回<br>20231222 又重新送回审稿人手里 under review<br>20231231 accept<br>全程有三个审稿人,一共提了20+个意见,审稿速度算飞速的了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Mon Jan 01 16:19:48 CST 2024, time=2024-01-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2186444, encodeId=2307218644450, content=没审稿,直接DIP 写信催给决定 ,回复以下,没动静了,有经验的大神在吗 怎么办 Your manuscript was transferred to our transfer team looking for a better suited journal. The transfer process may take a few days to complete.  When you receive a letter of confirmation of transfer, you can accept or decline the transfer. Best regards,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6a65458119, createdName=ms1000001139242253, createdTime=Thu Feb 08 05:53:18 CST 2024, time=2024-02-08, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向:分子生物学<br>经验分享:投稿第三天直接decision in process 请问这是直接拒稿吗?有没有相同经历的人 麻烦分享一下 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2170911, encodeId=33c021e09112b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:医学<br>经验分享:状态是with editor 之后变成 decision in process,这个状态要持续多久呀,已经一个礼拜了,也不送审。可以直接投下一个期刊吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20535460863, createdName=ms2000001577708140, createdTime=Sat Nov 25 12:53:20 CST 2023, time=2023-11-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了,外审时间都半年了,催了几次回复都一样。问一下大家,是不是审稿人不回复,编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2106235, encodeId=347b210623503, content=投稿一个月了,还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211226/b81eecd114f947a4b95c452618e5ebdc/32dc8969e6744e21929a0d643f10b777.jpg, createdBy=404c107315, createdName=Marvin2014, createdTime=Thu Dec 15 20:44:34 CST 2022, time=2022-12-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿,当天with editor。15号变成decision,现在还在等待决定。已经快一个月了,有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167530, encodeId=2f27216e53014, content=偏重的研究方向:生物材料<br>经验分享:两个月了 没有审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=Zhou zhongsheng, createdTime=Thu Nov 09 09:47:55 CST 2023, time=2023-11-09, status=1, ipAttribution=吉林省)]
    2024-02-08 ms1000001139242253 来自海南省

    没审稿,直接DIP 写信催给决定 ,回复以下,没动静了,有经验的大神在吗 怎么办 Your manuscript was transferred to our transfer team looking for a better suited journal. The transfer process may take a few days to complete.  When you receive a letter of confirmation of transfer, you can accept or decline the transfer. Best regards,

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=858882, encodeId=d4a9858882d1, content=嗯,很快,已经接收3篇了,友好的期刊和审稿人,当然提出的修改意见很中肯,希望该期刊志能尽快跨入一区,突破5分,还会支持的! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48345414140, createdName=ms7269483029162029, createdTime=Sun Mar 29 11:19:51 CST 2020, time=2020-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157657, encodeId=17f2215e657b5, content=偏重的研究方向:生物大分子<br>经验分享:我9.1号投的,当天with editor ,到现在都还没动静。有没有一样的呀? 有点着急了,看这个期刊最近都超级慢 - -, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c78e8753922, createdName=ms3000000496472263, createdTime=Thu Sep 14 12:47:03 CST 2023, time=2023-09-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2178606, encodeId=dc1521e860647, content=审稿速度:1.0<br>偏重的研究方向:基础医学;综述;肿瘤治疗<br>经验分享:20231023 初次投稿<br>20231025 reject 综述需要在题目里带有review,修改重投<br>20231026 重新投稿,两三天之后under review<br>20231120 结束审稿,给了一个月大修<br>20231219 修回<br>20231222 又重新送回审稿人手里 under review<br>20231231 accept<br>全程有三个审稿人,一共提了20+个意见,审稿速度算飞速的了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Mon Jan 01 16:19:48 CST 2024, time=2024-01-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2186444, encodeId=2307218644450, content=没审稿,直接DIP 写信催给决定 ,回复以下,没动静了,有经验的大神在吗 怎么办 Your manuscript was transferred to our transfer team looking for a better suited journal. The transfer process may take a few days to complete.  When you receive a letter of confirmation of transfer, you can accept or decline the transfer. Best regards,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6a65458119, createdName=ms1000001139242253, createdTime=Thu Feb 08 05:53:18 CST 2024, time=2024-02-08, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向:分子生物学<br>经验分享:投稿第三天直接decision in process 请问这是直接拒稿吗?有没有相同经历的人 麻烦分享一下 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2170911, encodeId=33c021e09112b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:医学<br>经验分享:状态是with editor 之后变成 decision in process,这个状态要持续多久呀,已经一个礼拜了,也不送审。可以直接投下一个期刊吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20535460863, createdName=ms2000001577708140, createdTime=Sat Nov 25 12:53:20 CST 2023, time=2023-11-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了,外审时间都半年了,催了几次回复都一样。问一下大家,是不是审稿人不回复,编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2106235, encodeId=347b210623503, content=投稿一个月了,还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211226/b81eecd114f947a4b95c452618e5ebdc/32dc8969e6744e21929a0d643f10b777.jpg, createdBy=404c107315, createdName=Marvin2014, createdTime=Thu Dec 15 20:44:34 CST 2022, time=2022-12-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿,当天with editor。15号变成decision,现在还在等待决定。已经快一个月了,有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167530, encodeId=2f27216e53014, content=偏重的研究方向:生物材料<br>经验分享:两个月了 没有审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=Zhou zhongsheng, createdTime=Thu Nov 09 09:47:55 CST 2023, time=2023-11-09, status=1, ipAttribution=吉林省)]
    2023-09-11 Markxiao 来自香港

    偏重的研究方向:分子生物学
    经验分享:投稿第三天直接decision in process 请问这是直接拒稿吗?有没有相同经历的人 麻烦分享一下 谢谢

    6

    展开6条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=858882, encodeId=d4a9858882d1, content=嗯,很快,已经接收3篇了,友好的期刊和审稿人,当然提出的修改意见很中肯,希望该期刊志能尽快跨入一区,突破5分,还会支持的! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48345414140, createdName=ms7269483029162029, createdTime=Sun Mar 29 11:19:51 CST 2020, time=2020-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157657, encodeId=17f2215e657b5, content=偏重的研究方向:生物大分子<br>经验分享:我9.1号投的,当天with editor ,到现在都还没动静。有没有一样的呀? 有点着急了,看这个期刊最近都超级慢 - -, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c78e8753922, createdName=ms3000000496472263, createdTime=Thu Sep 14 12:47:03 CST 2023, time=2023-09-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2178606, encodeId=dc1521e860647, content=审稿速度:1.0<br>偏重的研究方向:基础医学;综述;肿瘤治疗<br>经验分享:20231023 初次投稿<br>20231025 reject 综述需要在题目里带有review,修改重投<br>20231026 重新投稿,两三天之后under review<br>20231120 结束审稿,给了一个月大修<br>20231219 修回<br>20231222 又重新送回审稿人手里 under review<br>20231231 accept<br>全程有三个审稿人,一共提了20+个意见,审稿速度算飞速的了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Mon Jan 01 16:19:48 CST 2024, time=2024-01-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2186444, encodeId=2307218644450, content=没审稿,直接DIP 写信催给决定 ,回复以下,没动静了,有经验的大神在吗 怎么办 Your manuscript was transferred to our transfer team looking for a better suited journal. The transfer process may take a few days to complete.  When you receive a letter of confirmation of transfer, you can accept or decline the transfer. Best regards,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6a65458119, createdName=ms1000001139242253, createdTime=Thu Feb 08 05:53:18 CST 2024, time=2024-02-08, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向:分子生物学<br>经验分享:投稿第三天直接decision in process 请问这是直接拒稿吗?有没有相同经历的人 麻烦分享一下 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2170911, encodeId=33c021e09112b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:医学<br>经验分享:状态是with editor 之后变成 decision in process,这个状态要持续多久呀,已经一个礼拜了,也不送审。可以直接投下一个期刊吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20535460863, createdName=ms2000001577708140, createdTime=Sat Nov 25 12:53:20 CST 2023, time=2023-11-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了,外审时间都半年了,催了几次回复都一样。问一下大家,是不是审稿人不回复,编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2106235, encodeId=347b210623503, content=投稿一个月了,还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211226/b81eecd114f947a4b95c452618e5ebdc/32dc8969e6744e21929a0d643f10b777.jpg, createdBy=404c107315, createdName=Marvin2014, createdTime=Thu Dec 15 20:44:34 CST 2022, time=2022-12-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿,当天with editor。15号变成decision,现在还在等待决定。已经快一个月了,有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167530, encodeId=2f27216e53014, content=偏重的研究方向:生物材料<br>经验分享:两个月了 没有审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=Zhou zhongsheng, createdTime=Thu Nov 09 09:47:55 CST 2023, time=2023-11-09, status=1, ipAttribution=吉林省)]
    2023-11-25 ms2000001577708140 来自广东省

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:医学
    经验分享:状态是with editor 之后变成 decision in process,这个状态要持续多久呀,已经一个礼拜了,也不送审。可以直接投下一个期刊吗?

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=858882, encodeId=d4a9858882d1, content=嗯,很快,已经接收3篇了,友好的期刊和审稿人,当然提出的修改意见很中肯,希望该期刊志能尽快跨入一区,突破5分,还会支持的! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48345414140, createdName=ms7269483029162029, createdTime=Sun Mar 29 11:19:51 CST 2020, time=2020-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157657, encodeId=17f2215e657b5, content=偏重的研究方向:生物大分子<br>经验分享:我9.1号投的,当天with editor ,到现在都还没动静。有没有一样的呀? 有点着急了,看这个期刊最近都超级慢 - -, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c78e8753922, createdName=ms3000000496472263, createdTime=Thu Sep 14 12:47:03 CST 2023, time=2023-09-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2178606, encodeId=dc1521e860647, content=审稿速度:1.0<br>偏重的研究方向:基础医学;综述;肿瘤治疗<br>经验分享:20231023 初次投稿<br>20231025 reject 综述需要在题目里带有review,修改重投<br>20231026 重新投稿,两三天之后under review<br>20231120 结束审稿,给了一个月大修<br>20231219 修回<br>20231222 又重新送回审稿人手里 under review<br>20231231 accept<br>全程有三个审稿人,一共提了20+个意见,审稿速度算飞速的了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Mon Jan 01 16:19:48 CST 2024, time=2024-01-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2186444, encodeId=2307218644450, content=没审稿,直接DIP 写信催给决定 ,回复以下,没动静了,有经验的大神在吗 怎么办 Your manuscript was transferred to our transfer team looking for a better suited journal. The transfer process may take a few days to complete.  When you receive a letter of confirmation of transfer, you can accept or decline the transfer. Best regards,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6a65458119, createdName=ms1000001139242253, createdTime=Thu Feb 08 05:53:18 CST 2024, time=2024-02-08, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向:分子生物学<br>经验分享:投稿第三天直接decision in process 请问这是直接拒稿吗?有没有相同经历的人 麻烦分享一下 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2170911, encodeId=33c021e09112b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:医学<br>经验分享:状态是with editor 之后变成 decision in process,这个状态要持续多久呀,已经一个礼拜了,也不送审。可以直接投下一个期刊吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20535460863, createdName=ms2000001577708140, createdTime=Sat Nov 25 12:53:20 CST 2023, time=2023-11-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了,外审时间都半年了,催了几次回复都一样。问一下大家,是不是审稿人不回复,编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2106235, encodeId=347b210623503, content=投稿一个月了,还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211226/b81eecd114f947a4b95c452618e5ebdc/32dc8969e6744e21929a0d643f10b777.jpg, createdBy=404c107315, createdName=Marvin2014, createdTime=Thu Dec 15 20:44:34 CST 2022, time=2022-12-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿,当天with editor。15号变成decision,现在还在等待决定。已经快一个月了,有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167530, encodeId=2f27216e53014, content=偏重的研究方向:生物材料<br>经验分享:两个月了 没有审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=Zhou zhongsheng, createdTime=Thu Nov 09 09:47:55 CST 2023, time=2023-11-09, status=1, ipAttribution=吉林省)]
    2023-10-12 superzera 来自广东省

    投稿7个月了,外审时间都半年了,催了几次回复都一样。问一下大家,是不是审稿人不回复,编辑就一直等

    14

    展开14条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=858882, encodeId=d4a9858882d1, content=嗯,很快,已经接收3篇了,友好的期刊和审稿人,当然提出的修改意见很中肯,希望该期刊志能尽快跨入一区,突破5分,还会支持的! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48345414140, createdName=ms7269483029162029, createdTime=Sun Mar 29 11:19:51 CST 2020, time=2020-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157657, encodeId=17f2215e657b5, content=偏重的研究方向:生物大分子<br>经验分享:我9.1号投的,当天with editor ,到现在都还没动静。有没有一样的呀? 有点着急了,看这个期刊最近都超级慢 - -, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c78e8753922, createdName=ms3000000496472263, createdTime=Thu Sep 14 12:47:03 CST 2023, time=2023-09-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2178606, encodeId=dc1521e860647, content=审稿速度:1.0<br>偏重的研究方向:基础医学;综述;肿瘤治疗<br>经验分享:20231023 初次投稿<br>20231025 reject 综述需要在题目里带有review,修改重投<br>20231026 重新投稿,两三天之后under review<br>20231120 结束审稿,给了一个月大修<br>20231219 修回<br>20231222 又重新送回审稿人手里 under review<br>20231231 accept<br>全程有三个审稿人,一共提了20+个意见,审稿速度算飞速的了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Mon Jan 01 16:19:48 CST 2024, time=2024-01-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2186444, encodeId=2307218644450, content=没审稿,直接DIP 写信催给决定 ,回复以下,没动静了,有经验的大神在吗 怎么办 Your manuscript was transferred to our transfer team looking for a better suited journal. The transfer process may take a few days to complete.  When you receive a letter of confirmation of transfer, you can accept or decline the transfer. Best regards,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6a65458119, createdName=ms1000001139242253, createdTime=Thu Feb 08 05:53:18 CST 2024, time=2024-02-08, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向:分子生物学<br>经验分享:投稿第三天直接decision in process 请问这是直接拒稿吗?有没有相同经历的人 麻烦分享一下 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2170911, encodeId=33c021e09112b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:医学<br>经验分享:状态是with editor 之后变成 decision in process,这个状态要持续多久呀,已经一个礼拜了,也不送审。可以直接投下一个期刊吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20535460863, createdName=ms2000001577708140, createdTime=Sat Nov 25 12:53:20 CST 2023, time=2023-11-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了,外审时间都半年了,催了几次回复都一样。问一下大家,是不是审稿人不回复,编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2106235, encodeId=347b210623503, content=投稿一个月了,还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211226/b81eecd114f947a4b95c452618e5ebdc/32dc8969e6744e21929a0d643f10b777.jpg, createdBy=404c107315, createdName=Marvin2014, createdTime=Thu Dec 15 20:44:34 CST 2022, time=2022-12-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿,当天with editor。15号变成decision,现在还在等待决定。已经快一个月了,有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167530, encodeId=2f27216e53014, content=偏重的研究方向:生物材料<br>经验分享:两个月了 没有审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=Zhou zhongsheng, createdTime=Thu Nov 09 09:47:55 CST 2023, time=2023-11-09, status=1, ipAttribution=吉林省)]
    2022-12-15 Marvin2014 来自江苏省

    投稿一个月了,还在under review

    9

    展开9条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=858882, encodeId=d4a9858882d1, content=嗯,很快,已经接收3篇了,友好的期刊和审稿人,当然提出的修改意见很中肯,希望该期刊志能尽快跨入一区,突破5分,还会支持的! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48345414140, createdName=ms7269483029162029, createdTime=Sun Mar 29 11:19:51 CST 2020, time=2020-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157657, encodeId=17f2215e657b5, content=偏重的研究方向:生物大分子<br>经验分享:我9.1号投的,当天with editor ,到现在都还没动静。有没有一样的呀? 有点着急了,看这个期刊最近都超级慢 - -, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c78e8753922, createdName=ms3000000496472263, createdTime=Thu Sep 14 12:47:03 CST 2023, time=2023-09-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2178606, encodeId=dc1521e860647, content=审稿速度:1.0<br>偏重的研究方向:基础医学;综述;肿瘤治疗<br>经验分享:20231023 初次投稿<br>20231025 reject 综述需要在题目里带有review,修改重投<br>20231026 重新投稿,两三天之后under review<br>20231120 结束审稿,给了一个月大修<br>20231219 修回<br>20231222 又重新送回审稿人手里 under review<br>20231231 accept<br>全程有三个审稿人,一共提了20+个意见,审稿速度算飞速的了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Mon Jan 01 16:19:48 CST 2024, time=2024-01-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2186444, encodeId=2307218644450, content=没审稿,直接DIP 写信催给决定 ,回复以下,没动静了,有经验的大神在吗 怎么办 Your manuscript was transferred to our transfer team looking for a better suited journal. The transfer process may take a few days to complete.  When you receive a letter of confirmation of transfer, you can accept or decline the transfer. Best regards,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6a65458119, createdName=ms1000001139242253, createdTime=Thu Feb 08 05:53:18 CST 2024, time=2024-02-08, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向:分子生物学<br>经验分享:投稿第三天直接decision in process 请问这是直接拒稿吗?有没有相同经历的人 麻烦分享一下 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2170911, encodeId=33c021e09112b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:医学<br>经验分享:状态是with editor 之后变成 decision in process,这个状态要持续多久呀,已经一个礼拜了,也不送审。可以直接投下一个期刊吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20535460863, createdName=ms2000001577708140, createdTime=Sat Nov 25 12:53:20 CST 2023, time=2023-11-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了,外审时间都半年了,催了几次回复都一样。问一下大家,是不是审稿人不回复,编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2106235, encodeId=347b210623503, content=投稿一个月了,还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211226/b81eecd114f947a4b95c452618e5ebdc/32dc8969e6744e21929a0d643f10b777.jpg, createdBy=404c107315, createdName=Marvin2014, createdTime=Thu Dec 15 20:44:34 CST 2022, time=2022-12-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿,当天with editor。15号变成decision,现在还在等待决定。已经快一个月了,有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167530, encodeId=2f27216e53014, content=偏重的研究方向:生物材料<br>经验分享:两个月了 没有审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=Zhou zhongsheng, createdTime=Thu Nov 09 09:47:55 CST 2023, time=2023-11-09, status=1, ipAttribution=吉林省)]
    2023-06-06 gyoun9 来自北京

    10号投稿,当天with editor。15号变成decision,现在还在等待决定。已经快一个月了,有相同经历的朋友吗

    15

    展开15条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=858882, encodeId=d4a9858882d1, content=嗯,很快,已经接收3篇了,友好的期刊和审稿人,当然提出的修改意见很中肯,希望该期刊志能尽快跨入一区,突破5分,还会支持的! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48345414140, createdName=ms7269483029162029, createdTime=Sun Mar 29 11:19:51 CST 2020, time=2020-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157657, encodeId=17f2215e657b5, content=偏重的研究方向:生物大分子<br>经验分享:我9.1号投的,当天with editor ,到现在都还没动静。有没有一样的呀? 有点着急了,看这个期刊最近都超级慢 - -, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c78e8753922, createdName=ms3000000496472263, createdTime=Thu Sep 14 12:47:03 CST 2023, time=2023-09-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2178606, encodeId=dc1521e860647, content=审稿速度:1.0<br>偏重的研究方向:基础医学;综述;肿瘤治疗<br>经验分享:20231023 初次投稿<br>20231025 reject 综述需要在题目里带有review,修改重投<br>20231026 重新投稿,两三天之后under review<br>20231120 结束审稿,给了一个月大修<br>20231219 修回<br>20231222 又重新送回审稿人手里 under review<br>20231231 accept<br>全程有三个审稿人,一共提了20+个意见,审稿速度算飞速的了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Mon Jan 01 16:19:48 CST 2024, time=2024-01-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2186444, encodeId=2307218644450, content=没审稿,直接DIP 写信催给决定 ,回复以下,没动静了,有经验的大神在吗 怎么办 Your manuscript was transferred to our transfer team looking for a better suited journal. The transfer process may take a few days to complete.  When you receive a letter of confirmation of transfer, you can accept or decline the transfer. Best regards,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6a65458119, createdName=ms1000001139242253, createdTime=Thu Feb 08 05:53:18 CST 2024, time=2024-02-08, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向:分子生物学<br>经验分享:投稿第三天直接decision in process 请问这是直接拒稿吗?有没有相同经历的人 麻烦分享一下 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2170911, encodeId=33c021e09112b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:医学<br>经验分享:状态是with editor 之后变成 decision in process,这个状态要持续多久呀,已经一个礼拜了,也不送审。可以直接投下一个期刊吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20535460863, createdName=ms2000001577708140, createdTime=Sat Nov 25 12:53:20 CST 2023, time=2023-11-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了,外审时间都半年了,催了几次回复都一样。问一下大家,是不是审稿人不回复,编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2106235, encodeId=347b210623503, content=投稿一个月了,还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211226/b81eecd114f947a4b95c452618e5ebdc/32dc8969e6744e21929a0d643f10b777.jpg, createdBy=404c107315, createdName=Marvin2014, createdTime=Thu Dec 15 20:44:34 CST 2022, time=2022-12-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿,当天with editor。15号变成decision,现在还在等待决定。已经快一个月了,有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167530, encodeId=2f27216e53014, content=偏重的研究方向:生物材料<br>经验分享:两个月了 没有审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=Zhou zhongsheng, createdTime=Thu Nov 09 09:47:55 CST 2023, time=2023-11-09, status=1, ipAttribution=吉林省)]
    2023-11-09 Zhou zhongsheng 来自吉林省

    偏重的研究方向:生物材料
    经验分享:两个月了 没有审稿人

    3

    展开3条回复
共436条页码: 1/44页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分